跳至主要内容
临床试验/NCT02501148
NCT02501148已完成不适用

A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection

Contego Medical, Inc.5 个研究点 分布在 1 个国家目标入组 106 人开始时间: 2015年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
106
试验地点
5
主要终点
Device-related MAE

研究概览

简要总结

The purpose of this study is to assess the safety and clinical performance of Paladin System in patients with carotid artery stenosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Documented stenotic atherosclerotic lesion located at carotid bifurcation and / or proximal internal carotid artery (ICA)
  • Subject is either (A) symptomatic within 6 months of procedure, with an ipsilateral carotid stenosis ≥ 50% by angiography, or (B) asymptomatic with carotid stenosis ≥ 70% by angiography
  • Target lesion can be covered by a single stent of no more than 40 mm in length
  • Target lesion reference vessel diameter (RVD) is 4.0 mm - 7.0mm
  • Sufficient landing zone required for successful deployment of integrated embolic protection filter
  • Willing to comply with all follow-up required study visits
  • Provision of written informed consent before index procedure

排除标准

  • Life expectancy of less than one year
  • An evolving, acute or recent stroke within 14 days of study evaluation
  • Acute myocardial infarction within 72 hours before procedure
  • Known sensitivity to contrast media that cannot be adequately controlled with pre-medication
  • Subject has a total occlusion of target carotid artery
  • Subject has a previously place stent in ipsilateral carotid artery
  • Severe circumferential lesion calcification that may restrict full deployment of carotid stent
  • Presence of filling defect or thrombus in target vessel
  • Presence of "string sign" of target vessel
  • Carotid (intracranial) stenosis located distal to target lesion
  • Greater than 50% stenosis of common carotid artery proximal to target lesion.
  • Known mobile plaque in aortic arch

结局指标

主要结局

Device-related MAE

时间窗: 30 days

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验